Anesthesiology, Pain Medicine · Fort Myers, FL
NPI
1619978236
Since 2005
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
7964 Summerlin Lakes Dr
Fort Myers, FL, 33907
Phone (239) 333-1177
Groups this clinician bills Medicare through
Medicare paid, 2024
$782K
12,407 services
Medicare patients, 2024
780
Average age 75
Drug cost, 2024
$660K
10,162 prescriptions
Company payments, 2025
$1,408
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eugene D Mahaney was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 1,248 times for 145 patients. In total Eugene D Mahaney billed 12,407 services in 102 codes, and Medicare paid $782K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,248 | 145 | $0.69 | $861 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 944 | 12 | $0.09 | $85.81 |
| J7325 Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 704 | 13 | $6.88 | $4,841 |
| 62323 Nerve Block Injection - Back | Office | 299 | 193 | $197.20 | $59K |
| 77002 Imaging - Miscellaneous | Office | 254 | 147 | $88.84 | $23K |
| 20610 Joint Injection | Office | 241 | 129 | $59.43 | $14K |
| 64483 Nerve Block Injection - Back | Office | 203 | 123 | $221.08 | $45K |
| 99204 Office E&M - New | Office | 191 | 191 | $129.32 | $25K |
| 64494 Nerve Block Injection - Back | Office | 190 | 113 | $104.95 | $20K |
| 64493 Nerve Block Injection - Back | Office | 190 | 112 | $193.53 | $37K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 183 | 145 | $274.46 | $50K |
| 64635 Destruction by Neurolytic Agent - Back | Office | 182 | 145 | $500.43 | $91K |
| 27096 Joint Injection | Office | 171 | 117 | $165.48 | $28K |
| 99213 Office E&M - Established | Office | 154 | 117 | $69.94 | $11K |
| 64484 Nerve Block Injection - Back | Office | 123 | 77 | $88.48 | $11K |
By year: 2022 $1.2M for 23,820 services; 2023 $888K for 16,799 services; 2024 $782K for 12,407 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 64 | 62 | $12.35 | $790 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 35 | 35 | $112.14 | $3,925 |
| 80307 Drug Tests | 15 | 15 | $60.90 | $914 |
Medicare prescription drug claims, 2024
In 2024, the drug Eugene D Mahaney prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 1,856 prescriptions and refills. In total Eugene D Mahaney wrote 10,162 Medicare prescriptions that cost $660K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,856 | 1,860 | 377 | $71K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,777 | 1,793 | 374 | $59K |
| Tramadol Hcl Generic | 997 | 1,029 | 255 | $11K |
| Morphine Sulfate Er Morphine Sulfate | 879 | 879 | 166 | $29K |
| Oxycodone Hcl Generic | 832 | 832 | 201 | $14K |
| Gabapentin Generic | 419 | 725 | 130 | $9,277 |
| Morphine Sulfate Generic | 371 | 371 | 78 | $12K |
| Pregabalin Generic | 326 | 468 | 107 | $12K |
| Fentanyl Generic | 227 | 227 | 34 | $23K |
| Methadone Hcl Generic | 193 | 195 | 31 | $4,445 |
| Xtampza Er Oxycodone Myristate | 179 | 179 | 32 | $131K |
| Buprenorphine Generic | 177 | 177 | 52 | $34K |
| Hydromorphone Hcl Generic | 164 | 164 | 35 | $3,138 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 155 | 158 | 47 | $2,848 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 143 | 143 | 25 | $20K |
Brand drugs: 758 claims; generic drugs: 9,404 claims; opioid claims: 8,101.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eugene D Mahaney $1,408 ($1,408 in general payments such as food, travel and fees) from 14 companies. The largest payer was Medtronic, Inc. with $321.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 13 | $321 |
| Boston Scientific Corporation BSX | 14 | $286 |
| Spinefrontier, Inc. | 1 | $165 |
| Abbott Laboratories ABT | 6 | $134 |
| Curonix LLC | 1 | $119 |
| Abbvie Inc. ABBV | 4 | $85.83 |
| TerSera Therapeutics LLC | 3 | $84.65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $59.76 |
| Foundation Fusion Solutions, LLC | 2 | $35.5 |
| Merz Pharmaceuticals, LLC | 1 | $27.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.